Publications by authors named "A Emmel"
Article Synopsis
- Introducing new genes and species into ecosystems can provide benefits like preventing extinctions, but it also poses risks and raises ethical concerns.
- The conservation community has made attempts to create guidelines, yet there is a need for broader principles to help navigate these complex decisions.
- This text proposes an inclusive set of principles that consider biological, legal, social, cultural, and ethical factors to assist conservation managers in making informed choices about emerging technologies.
Article Synopsis
- Neuromorphic systems are new types of computer systems that help scientists explore and research better, but making them easy to use and efficient is tricky.
- The BrainScaleS-2 system is a special kind of neuromorphic hardware that uses unique software features to make it easier for researchers to run experiments.
- The text talks about improvements like faster training methods, new types of neurons, and better access for users, plus plans for making the hardware even bigger and easier to work with in the future.
The remediation of four different soils contaminated by gasoline was performed using Fenton processes. Herein, the effect of the main physicochemical characteristics of the soils in the Fenton performance is emphasized. Fenton processes were applied in a column system, with and without addition of soluble iron (II), using undisturbed soil samples collected in four regions of the Paraná State (Brazil).
View Article and Find Full Text PDFObjectives: We sought to determine the speed at which patients were accrued into published phase III oncology trials across geographic locations and to identify the factors that may influence this process.
Materials And Methods: We searched OVID-Medline and identified all phase III oncology therapeutic trials published in 2006 to 2010. The speed of accrual for each trial was calculated by dividing the number of patients enrolled by the number of months the trial was open (patients/mo).
Objectives: Translation of evidence-based medicine into oncology practice depends on timely and full publication of clinical trials. We investigated publication outcomes of Phase II trial abstracts from the annual meetings of the American Society of Clinical Oncology (ASCO).
Methods: We searched the 1997, 1999, and 2001 ASCO annual meeting proceedings and identified all Phase II trials, excluding those that reported preliminary results.